Viewing Study NCT04485156


Ignite Creation Date: 2025-12-24 @ 11:37 PM
Ignite Modification Date: 2025-12-25 @ 9:27 PM
Study NCT ID: NCT04485156
Status: NOT_YET_RECRUITING
Last Update Posted: 2020-07-24
First Post: 2020-07-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Treatment Shortening of Drug-Sensitive Pulmonary Tuberculosis Using High Dose Rifampicin (Hi-DoRi-3)
Sponsor: Seoul National University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module